Rev Esp Salud Publica. 1996 Mar-Apr;70(2):139-210.
Arterial Hypertension remains a serious public health problem in Spain, given its high degree of prevalence (20% to 30% of individuals suffer from hypertension, the figure increasing with age) and contributes to the main cause of death in the country, that being cardiovascular disease. 15-20% of coronary caused deaths and 20-25% of cerebral vascular deaths of Spanish adults are attributed to arterial hypertension. The level of control, despite having improved, is still low (less than 30% of patients treated). Therapeutic observation does not exceed 50%. Costs are extremely high, close to 120,000 million pesetas per annum (pharmacological treatment comprising 10-20% of the figure). Despite the progress achieved in recent years, the above mentioned figures justify the need to continue promoting and combine activities designed to deal with the problem, such as those referred to in this report. The report is directed to health professionals involved in arterial hypertension work and is intended to achieve greater levels of prevention and control of such a serious problem in Spain. A team of Spanish experts describe updated and consensual issues relating to the criteria defining arterial hypertension in adults, children and pregnant women; refractory and accelerated/malignant hypertension and serious and emergency cases of hypertension; accurate measurement of blood pressure and measuring techniques (including MAPA); diagnosis and control of hypertension (highlighting the role of Primary Medical and Hospital Services); pharmacological and non-pharmacological treatment objectives and programmes; hypertension considerations associated to special situations; as well as health education and patient compliance with therapy and bio-ethical, effectiveness, research and training issues.
在西班牙,动脉高血压仍然是一个严重的公共卫生问题,这是因为其患病率很高(20%至30%的人患有高血压,且该数字随年龄增长而增加),并且它是该国主要的死亡原因,即心血管疾病的一个成因。西班牙成年人中15%至20%的冠心病致死病例以及20%至25%的脑血管疾病致死病例都归因于动脉高血压。尽管控制水平有所提高,但仍然很低(接受治疗的患者中不到30%)。治疗观察率不超过50%。成本极高,每年接近1200亿比塞塔(药物治疗占该数字的10%至20%)。尽管近年来取得了进展,但上述数字表明仍有必要继续推动并整合旨在解决该问题的活动,比如本报告中提及的那些活动。本报告面向从事动脉高血压工作的卫生专业人员,旨在在西班牙更有效地预防和控制这一严重问题。一组西班牙专家描述了与成人、儿童和孕妇动脉高血压定义标准;难治性和急进性/恶性高血压以及严重和紧急高血压病例;血压的准确测量和测量技术(包括动态血压监测);高血压的诊断和控制(强调初级医疗和医院服务的作用);药物和非药物治疗目标及方案;与特殊情况相关的高血压注意事项;以及健康教育和患者对治疗的依从性以及生物伦理、有效性、研究和培训问题等相关的最新且达成共识的问题。